Here are three details:
1. Proceeds of the financing will go toward the expansion and clinical development of Providence’s DTRAX line of cervical fusion instruments.
2. The DTRAX Spinal System has been installed at more than 1,800 U.S. hospitals.
3. Revelation Partners, BMO Global Asset Management, MVM Life Science Partners, Medvest Capital and Aphelion Capital contributed to the financing.
More articles on devices:
Medtronic, Zimmer Biomet, Smith & Nephew & more: 15 device company notes
18 spine devices received FDA 510(k) clearance in August
Medtronic joins initiative to bring more women into board seats
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
